BioSpace News Archive

The Journal of Clinical Aesthetic Dermatology published a pioneering clinical research study by Sanusi Umar MD from Dr. U Hair and Skin Clinic, Delphine Lee MD, Ph.D., and Jenna J. Lullo MD

A new study of Soliqua® 100/33 100 Units/mL and 33 mcg/mL, iGlarLixi, met its two primary endpoints and all key secondary endpoints in a head-to-head comparison against premixed insulin in adults living with type 2 diabetes, the most common form of diabetes, uncontrolled on insulin and one or two oral anti-diabetic medicines.

Intertek, a leading Total Quality Assurance provider to industries worldwide, and Globizz, a leading Japanese-U.S. medical device consulting firm, have entered a partnership offering regulatory consulting, technical services, and strategic planning for medical device manufacturers in Japan and the United States.

REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing CoSci-REMD Bio (“Cosci‑REMD Bio”), today announced positive top-line results from a phase 2 clinical program of volagidemab (“Vola”) in patients with type 1 diabetes were presented at the American Diabetes Associations (ADA) 81st Scientific Session

Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) has accepted its Investigational New Drug (IND) application for JS014.

Maya has developed a measurement-based care platform designed to support psychedelic practitioners and patients.

Movement Industries Corporation (OTC PINK: MVNT) (the “Company”) is excited to announce the product launch of iChem. iChem is a fully integrated SaaS (Software as a Service) product with a hardware platform based on cellular and satellite communications modules and allows monitoring and control of all chemical injection assets

Nimble Therapeutics and RayzeBio today announced the companies have entered a strategic collaboration to discover and develop novel peptide-based radiopharmaceuticals for treatment of cancer.

From the world’s #1 selling nerve care company,†† P&G Personal Health Care is excited to announce Nervive, a dietary supplement lineup dedicated to holistic nerve care and relief*.

The report highlights trends prevailing in the global ePRO, epatient diaries, and eCOA market, and the factors driving and restraining the market growth.